NTEC
Income statement / Annual
Last year (2020), Intec Pharma Ltd's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2020, Intec Pharma Ltd's net income was -$14.13 M.
See Intec Pharma Ltd,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$6.74 M
|
$26.66 M
|
$35.40 M
|
$24.30 M
|
$10.75 M
|
$4.79 M
|
$3.41 M
|
$2.59 M
|
| General & Administrative Expenses |
$7.09 M
|
$8.29 M
|
$7.93 M
|
$5.12 M
|
$3.07 M
|
$2.75 M
|
$2.59 M
|
$2.74 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.09 M
|
$8.29 M
|
$7.93 M
|
$5.12 M
|
$3.07 M
|
$2.75 M
|
$2.59 M
|
$2.74 M
|
| Other Expenses |
$0.00
|
-$1.50 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$13.83 M
|
$33.45 M
|
$43.33 M
|
$29.41 M
|
$13.82 M
|
$7.54 M
|
$6.00 M
|
$5.33 M
|
| Cost And Expenses |
$13.83 M
|
$33.45 M
|
$43.33 M
|
$29.44 M
|
$13.85 M
|
$7.56 M
|
$6.02 M
|
$5.36 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$15.00 K
|
$23.00 K
|
$17.00 K
|
$16.00 K
|
$15.37 K
|
$23.00 K
|
$24.41 K
|
| Depreciation & Amortization |
$1.20 M
|
$854.00 K
|
$859.00 K
|
$829.00 K
|
$701.00 K
|
$742.38 K
|
$585.00 K
|
$624.84 K
|
| EBITDA |
-$12.80 M |
-$46.09 M |
-$42.56 M |
-$28.22 M |
-$12.65 M |
-$6.39 M |
-$5.09 M |
-$4.63 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$175.00 K
|
-$13.52 M
|
-$112.00 K
|
$375.00 K
|
$484.00 K
|
$421.40 K
|
$325.00 K
|
$74.66 K
|
| Income Before Tax |
-$14.00 M
|
-$46.96 M
|
-$43.44 M
|
-$29.06 M
|
-$13.36 M
|
-$7.14 M
|
-$5.69 M
|
-$5.28 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$124.00 K
|
$638.00 K
|
$103.00 K
|
$29.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$14.13 M
|
-$47.60 M
|
-$43.54 M
|
-$29.09 M
|
-$13.36 M
|
-$7.14 M
|
-$5.69 M
|
-$5.28 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-14.3 |
-112.74 |
-111.67 |
-131.79 |
-93.38 |
-73.35 |
-94.39 |
-97.75 |
| EPS Diluted |
-14.3 |
-112.74 |
-111.67 |
-131.79 |
-93.38 |
-73.35 |
-94.39 |
-97.75 |
| Weighted Average Shares Out |
$988.00 K
|
$422.20 K
|
$389.91 K
|
$220.75 K
|
$143.10 K
|
$97.39 K
|
$60.31 K
|
$54.03 K
|
| Weighted Average Shares Out Diluted |
$988.00 K
|
$422.20 K
|
$389.91 K
|
$220.75 K
|
$143.10 K
|
$97.39 K
|
$60.31 K
|
$54.03 K
|
| Link |
|
|
|
|
|
|
|
|
